We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$747M
AUM Growth
-$68.4M
Cap. Flow
-$45M
Cap. Flow %
-6.03%
Top 10 Hldgs %
35.25%
Holding
111
New
12
Increased
44
Reduced
34
Closed
21

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16.1M
2
PODD icon
Insulet
PODD
+$15.9M
3
ICLR icon
Icon
ICLR
+$11.6M
4
HUM icon
Humana
HUM
+$10.1M
5
BSX icon
Boston Scientific
BSX
+$9.23M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$17.4M
2
THC icon
Tenet Healthcare
THC
+$16.2M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$15.6M
4
COR icon
Cencora
COR
+$13.9M
5
OSCR icon
Oscar Health
OSCR
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.27%
2 Industrials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
1
Boston Scientific
BSX
$71.5B
$42.5M 5.69%
551,592
+126,119
+30% +$9.23M
PODD icon
2
Insulet
PODD
$9.79B
$36.2M 4.85%
179,305
+88,356
+97% +$15.9M
UTHR icon
3
United Therapeutics
UTHR
$23.1B
$35.5M 4.75%
111,381
-16,818
-13% -$4.45M
LLY icon
4
Eli Lilly
LLY
$1.06T
$28.7M 3.84%
31,654
-463
-1% -$370K
COO icon
5
Cooper Companies
COO
$14.5B
$26.9M 3.61%
308,398
+22,999
+8% +$2.15M
THC icon
6
Tenet Healthcare
THC
$21.1B
$19.8M 2.65%
148,927
-134,926
-48% -$16.2M
AGIO icon
7
Agios Pharmaceuticals
AGIO
$1.93B
$19.2M 2.58%
+446,416
New +$16.1M
LBPH
8
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$18.8M 2.51%
694,178
+1,034
+0.1% +$20.4K
RXST icon
9
RxSight
RXST
$260M
$17.9M 2.39%
296,739
-115,693
-28% -$6.61M
DXCM icon
10
DexCom
DXCM
$32B
$17.8M 2.38%
156,855
-14,810
-9% -$1.87M
BDX icon
11
Becton Dickinson
BDX
$48.7B
$15.9M 2.13%
68,167
+22,570
+49% +$5.32M
NBIX icon
12
Neurocrine Biosciences
NBIX
$16.6B
$15.9M 2.12%
115,170
-16,781
-13% -$2.3M
ELV icon
13
Elevance Health
ELV
$85.5B
$15M 2.01%
27,751
+12,587
+83% +$6.65M
SDGR icon
14
Schrodinger
SDGR
$1.36B
$14M 1.87%
721,373
-278,641
-28% -$6.42M
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.7M 1.7%
185,028
+115,136
+165% +$7.99M
ABT icon
16
Abbott
ABT
$187B
$12.7M 1.7%
121,913
+224
+0.2% +$23.8K
MNKD icon
17
MannKind Corp
MNKD
$1.32B
$12.6M 1.68%
2,409,599
+3,663
+0.2% +$16.6K
DAWN
18
DELISTED
Day One Biopharmaceuticals
DAWN
$12.5M 1.68%
908,822
+217,010
+31% +$3.18M
MRK icon
19
PUT
Merck
MRK
$318B
$12.4M 1.66%
+100,000
New +$12.9M
SNDX icon
20
Syndax Pharmaceuticals
SNDX
$1.82B
$12.3M 1.65%
600,698
-184,113
-23% -$3.85M
KNSA icon
21
Kiniksa Pharmaceuticals
KNSA
$5.93B
$12.1M 1.62%
647,142
+979
+0.2% +$18.3K
ICLR icon
22
Icon
ICLR
$12.7B
$11.6M 1.56%
+37,056
New +$11.6M
PCVX icon
23
Vaxcyte
PCVX
$8.64B
$11.3M 1.52%
150,191
+235
+0.2% +$16K
HUM icon
24
Humana
HUM
$46.2B
$11.2M 1.5%
+30,037
New +$10.1M
BCYC
25
Bicycle Therapeutics
BCYC
$292M
$10.8M 1.45%
535,063
+10,810
+2% +$244K
1
2 3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Parkman Healthcare Partners held 111 positions worth $747M, down 8.4% from $815M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners withdrew a net $45M in Q2 2024, closing 21 positions and reducing 34 holdings. Its most notable exit was Inspire Medical Systems, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Agios Pharmaceuticals worth $19.2M.

  • Parkman Healthcare Partners's largest Q2 2024 buy was Agios Pharmaceuticals: 446,416 shares worth $19.2M.
  • Parkman Healthcare Partners added most to Insulet in Q2 2024, an estimated $15.9M increase.
  • Parkman Healthcare Partners's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $16.2M.
  • Parkman Healthcare Partners fully exited Inspire Medical Systems in Q2 2024, selling an estimated $17.4M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $747M portfolio in Q2 2024.
  • Parkman Healthcare Partners opened 12 new positions and closed 21 in Q2 2024.
  • Parkman Healthcare Partners's portfolio value fell 8.4% quarter-over-quarter to $747M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.